Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Perillyl Alcohol · NEO100, NSC-641066

Small molecule · Inhibitor of farnesyl transferase (FNTA) and geranylgeranyl transferase (PGGT1B) · developed by Neonc Technologies

Phase 2 Most advanced trial
NTHI Developer
2 Registered trials

What is Perillyl Alcohol?

Perillyl alcohol (NEO100) is a naturally occurring monoterpene related to limonene. It inhibits farnesyl transferase and geranylgeranyl transferase, preventing protein farnesylation and isoprenylation and activation of oncoproteins such as p21-ras, and arresting tumor cells in the G1 phase. It is studied in glioblastoma multiforme and grade II or III meningioma.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
NEO100, NSC-641066
Drug type
Small molecule
Targets
farnesyl transferase (FNTA), geranylgeranyl transferase (PGGT1B)
Mechanism
Inhibitor of farnesyl transferase (FNTA) and geranylgeranyl transferase (PGGT1B)
Pathways
protein farnesylation, protein isoprenylation, p21-ras activation, G1 cell cycle arrest
Therapy area
Oncology
Developer
Neonc Technologies, Inc. (NTHI)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2
UNII
319R5C7293

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05023018 Phase 2 Residual, Progressive or Recurrent Grade II or III Meningioma Recruiting NTHI
NCT02704858 Phase 1/2 Glioblastoma Multiforme Active not recruiting NTHI

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Glioblastoma Multiforme

Other drugs acting on FNTA / PGGT1B

More from Neonc Technologies

Sources

Updated Oct 25, 2026. Something wrong or missing? Report it on the NTHI page.

Follow NTHI, the company behind Perillyl Alcohol

See NTHI's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

NTHI catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.